Leaflet VICTAN 2mg film-coated tablets


Indicated for: anxiety

Substance: ethyl loflazepate (anxiolytic)

ATC: N05BA18 (Nervous system | Anxiolytics | Benzodiazepine derivatives)

Ethyl loflazepate is a benzodiazepine medication used to treat severe anxiety and insomnia. It works by enhancing the effect of gamma-aminobutyric acid (GABA) in the brain, leading to a sedative and anxiolytic effect.

The medication is taken orally, usually in tablet form, and the dosage is adjusted based on the severity of symptoms and the patient's response. Treatment is recommended for short-term use to avoid the risk of dependence.

Side effects may include drowsiness, dizziness, muscle weakness, or confusion. In rare cases, paradoxical reactions such as agitation or irritability may occur.

Patients should avoid alcohol consumption and inform their doctor about any other medications they are taking. Pregnant or breastfeeding women should not use this medication without a specialist's recommendation.

General data about VICTAN 2mg

  • Substance: ethyl loflazepate
  • Date of last drug list: 01-04-2026
  • Commercial code: W53576001
  • Concentration: 2mg
  • Pharmaceutical form: film-coated tablets
  • Quantity: 20
  • Product type: generic
  • Prescription restrictions: TAB3 - Medicines that are issued with a special prescription (psychotropic) in green color.

Marketing authorisation

  • Manufacturer: SOFARIMEX INDUSTRIA QUIMICA E FARMACEUTICA - PORTUGALIA
  • Holder: SINTOFARM SA - ROMANIA
  • Number: 1106/2008/01
  • Shelf life: 3 years